ライフサイエンスコーパス: Fabry's disease

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 carriages, diabetes, autoimmune disease, and Fabry's disease).

2 casian male renal transplant recipients with Fabry's disease.

3 manifestations such as type I Gaucher's and Fabry's disease.

4 orts regarding the outcomes of patients with Fabry's disease after renal transplantation.

5 Fabry's disease, an X-linked disorder of lysosomal alpha

6 benefit of this treatment has been slight in Fabry's disease and is yet to be fully shown in the othe

7 y further elucidate HLA-based association of Fabry's disease and resistance to activated protein C wi

8 Patients with Fabry's disease demonstrated equivalent 5-year patient a

9 Fabry's disease (FD) is a rare, sex-linked disorder resu

10 hort, we suggest screening all patients with Fabry's disease for APCR.

11 evaluation of all transplant candidates with Fabry's disease for hypercoagulability.

12 that we used to categorize 67 patients with Fabry's disease for randomization to 6 months of double-

13 Gene defects causing Fabry's disease (GLA) and Pompe's disease (GAA) were not

14 lysosomes of fibroblasts from patients with Fabry's disease, GM1 gangliosidosis, GM2 gangliosidosis

15 cardiovascular complications, patients with Fabry's disease have excellent outcomes after renal tran

16 Among these rare orphan diseases are Fabry's disease, in which the heart, kidney, gastrointes

17 Fabry's disease is an X-linked error of glycosphingolipi

18 Fabry's disease is an X-linked lysosomal storage disorde

19 Fabry's disease is associated with an increased incidenc

20 Fabry's disease, lysosomal alpha-galactosidase A deficie

21 ral blood monocytes, APCR in the presence of Fabry's disease may be a nonimmunological stimulus for r

22 Analysis of HLA typing in patients with Fabry's disease may further elucidate HLA-based associat

23 several other lysosomal disorders, including Fabry's disease, Pompe's disease, lysosomal acid lipase

24 adaveric renal allograft in a recipient with Fabry's disease prompted prospective evaluation of all t

25 he kidneys, heart, and skin in patients with Fabry's disease, reversing the pathogenesis of the chief

26 ues such as the cardiac muscle and kidney in Fabry's disease, skeletal muscle in patients with Pompe'

27 s (83% and 75%, respectively, for those with Fabry's disease vs. 82% and 67% for controls).

28 Transplant candidates with Fabry's disease were tested for hypercoagulability, anal

29 om 1988 and 1998, and found 93 patients with Fabry's disease who had received a renal transplant.

30 enzyme replacement therapy in patients with Fabry's disease who were enrolled in the Fabry Outcome S

31 rical natural history data for patients with Fabry's disease who were not treated with enzyme replace

32 A unique association of Fabry's disease with activated protein C Resistance was

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。